10-QPeriod: Q1 FY2022

CARPENTER TECHNOLOGY CORP Quarterly Report for Q1 Ended Sep 30, 2021

Filed October 28, 2021For Securities:CRS

Summary

Carpenter Technology Corporation (CRS) reported its first fiscal quarter results ending September 30, 2021, showing a net loss of $14.8 million, an improvement from a net loss of $47.1 million in the prior year's comparable quarter. This narrowing of losses was driven by a 10% increase in net sales, reaching $387.6 million, primarily due to recovering demand in key markets like Medical, Transportation, and Industrial/Consumer, coupled with effective cost management and the completion of certain restructuring actions. Despite the sales growth, the company continues to face challenges, including ongoing supply chain disruptions and labor market tightness, which led to a temporary build-up in inventory and a negative $47.0 million in cash flow from operations. However, the company maintained a strong liquidity position with $507.8 million in total liquidity as of quarter-end, comprising cash and cash equivalents and available credit facilities. Management expressed confidence in a broad-based recovery, particularly in the aerospace sector, and its strategic positioning for future growth in its core business as well as in emerging areas like additive manufacturing.

Financial Statements
Beta
Revenue$387.60M
Gross Profit$25.20M
SG&A Expenses$44.30M
Operating Income-$19.10M
Interest Expense$10.20M
Net Income-$14.80M
EPS (Basic)$-0.31
EPS (Diluted)$-0.31
Shares Outstanding (Basic)48.50M
Shares Outstanding (Diluted)48.50M

Key Highlights

  • 1Net sales increased by 10% year-over-year to $387.6 million, indicating a recovery in demand across several key end-use markets.
  • 2Net loss narrowed significantly to $14.8 million from $47.1 million in the prior year's comparable quarter.
  • 3Gross profit improved to $25.2 million (6.5% of net sales) from $3.5 million (1.0% of net sales) in the prior year, with adjusted gross margin excluding surcharges also showing improvement.
  • 4Operating loss improved to $19.1 million from $48.8 million in the prior year, with adjusted operating margin excluding surcharges and special items showing a positive trend.
  • 5The company experienced a significant inventory build-up ($66.5 million increase), negatively impacting operating cash flow, attributed to supply chain and operational delays.
  • 6Total liquidity remained strong at $507.8 million, comprising $213.2 million in cash and cash equivalents and $294.6 million in available credit facilities.
  • 7Capital expenditures decreased to $14.4 million from $33.3 million year-over-year, with full-year fiscal 2022 capital expenditure expectations around $125 million.

Frequently Asked Questions

The primary driver for the improved financial results was a 10% increase in net sales to $387.6 million, supported by recovering demand in markets such as Medical, Transportation, and Industrial & Consumer. Additionally, the company benefited from cost-saving initiatives and the absence of significant restructuring charges seen in the prior year.

Operating cash flow was negatively impacted by a significant build-up in inventories, totaling $66.5 million for the quarter. Management attributes this temporary inventory increase to supply chain disruptions and short-term operational delays, including COVID-19 related issues.

The company reported strong total liquidity of $507.8 million as of September 30, 2021. This includes $213.2 million in cash and cash equivalents and $294.6 million in available borrowing capacity under its credit facility. Management believes this liquidity will be sufficient to meet its cash needs for the foreseeable future.

Sales to the Aerospace and Defense market saw a slight decrease of 3% year-over-year on a reported basis, and a 9% decrease excluding surcharge revenue. Despite this, the company sees signs of a broad-based recovery in the aerospace supply chain and expects acceleration of demand conditions in calendar year 2022.